|
US2909462A
(en)
|
1955-12-08 |
1959-10-20 |
Bristol Myers Co |
Acrylic acid polymer laxative compositions
|
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
US5505941A
(en)
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
|
US5110587A
(en)
|
1981-12-24 |
1992-05-05 |
Health Research, Incorporated |
Immunogenic composition comprising synthetically modified vaccinia virus
|
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
US5174993A
(en)
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
|
US5338683A
(en)
|
1981-12-24 |
1994-08-16 |
Health Research Incorporated |
Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
|
|
US4745051A
(en)
|
1983-05-27 |
1988-05-17 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
|
EP0173552B1
(en)
|
1984-08-24 |
1991-10-09 |
The Upjohn Company |
Recombinant dna compounds and the expression of polypeptides such as tpa
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
US4968615A
(en)
|
1985-12-18 |
1990-11-06 |
Ciba-Geigy Corporation |
Deoxyribonucleic acid segment from a virus
|
|
US4963481A
(en)
|
1985-12-18 |
1990-10-16 |
Genetics Institute Inc |
Promoter system
|
|
GB2197321B
(en)
|
1986-09-12 |
1990-10-03 |
Genentech Inc |
Method and vectors for obtaining continuous production of heterologous protein in a eukaryotic host cell line
|
|
IL84154A0
(en)
|
1986-10-16 |
1988-03-31 |
Microgenesys Inc |
Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
DE3743138A1
(de)
|
1987-12-18 |
1989-09-14 |
Mayr Christian Gmbh & Co Kg |
Schleifringlose, elektromagnetische ueberlastkupplung
|
|
CA2003300A1
(en)
|
1988-11-21 |
1990-05-21 |
Franklin Volvovitz |
Skin test and test kit for aids
|
|
EP0377842B1
(en)
*
|
1988-12-13 |
1995-10-04 |
President And Fellows Of Harvard College |
Prototype FeLV isolates for use in disease models and vaccines
|
|
US5843456A
(en)
|
1991-03-07 |
1998-12-01 |
Virogenetics Corporation |
Alvac poxvirus-rabies compositions and combination compositions and uses
|
|
EP0575491B1
(en)
|
1991-03-07 |
2003-08-13 |
Virogenetics Corporation |
Genetically engineered vaccine strain
|
|
US6133028A
(en)
|
1993-05-28 |
2000-10-17 |
Transgene S.A. |
Defective adenoviruses and corresponding complementation lines
|
|
FR2712603B1
(fr)
|
1993-11-18 |
1996-02-09 |
Centre Nat Rech Scient |
Virus recombinants, préparation et utilisation en thérapie génique.
|
|
US5529780A
(en)
|
1994-03-30 |
1996-06-25 |
Virogenetics Corporation |
Nucleotide and amino acid sequences of canine herpesvirus gB and gC
|
|
JPH11504631A
(ja)
|
1995-04-25 |
1999-04-27 |
バイカル インコーポレイテッド |
Ｄｎａ／脂質複合体の単一バイアル製剤
|
|
EP0803573A1
(en)
|
1996-04-25 |
1997-10-29 |
Gesellschaft für Biotechnologische Forschung mbH (GBF) |
Polycistronic expression construct with cytokines for multivalent vaccines
|
|
US5846946A
(en)
|
1996-06-14 |
1998-12-08 |
Pasteur Merieux Serums Et Vaccins |
Compositions and methods for administering Borrelia DNA
|
|
AU737243B2
(en)
|
1996-07-03 |
2001-08-16 |
Merial, Inc. |
Recombinant canine adenovirus (CAV) containing exogenous DNA
|
|
US6156567A
(en)
|
1996-07-03 |
2000-12-05 |
Merial |
Truncated transcriptionally active cytomegalovirus promoters
|
|
US6090393A
(en)
|
1996-07-03 |
2000-07-18 |
Merial |
Recombinant canine adenoviruses, method for making and uses thereof
|
|
FR2775601B1
(fr)
|
1998-03-03 |
2001-09-21 |
Merial Sas |
Vaccins vivants recombines et adjuves
|
|
FR2776928B1
(fr)
|
1998-04-03 |
2000-06-23 |
Merial Sas |
Vaccins adn adjuves
|
|
TWI224107B
(en)
|
1998-10-22 |
2004-11-21 |
Pfizer Prod Inc |
Novel proteins from actinobacillus pleuropneumoniae
|
|
US6017537A
(en)
|
1998-12-18 |
2000-01-25 |
Connaught Laboratories, Inc. |
Formyl methionyl peptide vaccine adjuvant
|
|
US6645740B1
(en)
|
1999-06-10 |
2003-11-11 |
Merial Limited |
Nucleic acids encodings equine GM-CSF
|
|
FR2796397B1
(fr)
|
1999-07-16 |
2006-09-01 |
Merial Sas |
Genes de calicivirus felin et vaccins notamment vaccins recombines
|
|
WO2001022972A2
(en)
|
1999-09-25 |
2001-04-05 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acids
|
|
US6852705B2
(en)
|
2000-01-21 |
2005-02-08 |
Merial |
DNA vaccines for farm animals, in particular bovines and porcines
|
|
EP1203819A3
(en)
|
2000-10-06 |
2002-08-07 |
Transgene S.A. |
Anti-inflammatory vectors
|
|
AU2002327338A1
(en)
*
|
2001-07-25 |
2003-02-17 |
New York University |
Use of glycosylceramides as adjuvants for vaccines against infections and cancer
|
|
FR2829498B1
(fr)
|
2001-09-11 |
2003-11-28 |
Merial Sas |
Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins
|
|
WO2003062374A2
(en)
|
2001-11-09 |
2003-07-31 |
Entremed, Inc. |
Synthetic genes for malarial proteins and methods of use
|
|
AU2003245416A1
(en)
|
2002-06-07 |
2004-04-30 |
University Of Florida |
Endodontic files made using bulk metallic glasses
|
|
WO2004028562A2
(de)
*
|
2002-09-23 |
2004-04-08 |
Mologen Ag |
Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze
|
|
AU2005229411B2
(en)
*
|
2004-03-30 |
2010-11-18 |
Centre National De La Recherche Scientifique |
Polypeptide sequence involved in the modulation of the immunosuppressive effect of viral proteins
|
|
US7582302B2
(en)
|
2004-06-04 |
2009-09-01 |
Merial Limited |
Needle-free administration of FeLV vaccines
|
|
US7998733B2
(en)
*
|
2004-10-05 |
2011-08-16 |
Merial Limited |
Chimeric vectors
|
|
ME01965B
(me)
*
|
2005-09-16 |
2012-04-30 |
Merial Ltd |
Stabilizatori za vakcine osušene zamrzavanjem
|
|
EP2155883A1
(en)
*
|
2007-05-30 |
2010-02-24 |
Wyeth LLC |
Raccoon poxvirus expressing genes of feline antigens
|